The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity, mAbs, vol.7, pp.331-343, 2015. ,
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity, J. Clin. Invest, vol.123, pp.2183-2192, 2013. ,
Effect of HIV antibody VRC01 on viral rebound after treatment interruption, N. Engl. J. Med, vol.375, pp.2037-2050, 2016. ,
Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors, Mol. Immunol, vol.46, pp.1878-1882, 2009. ,
Separation of nonfucosylated antibodies with immobilized FcgammaRIII receptors, Biotechnol. Prog, vol.29, pp.825-828, 2013. ,
NGlycosylation of plant-produced recombinant proteins, Curr. Pharm. Design, vol.19, pp.5503-5512, 2013. ,
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity, Cell, vol.158, pp.1243-1253, 2014. ,
Crystal structure of the complex of rat neonatal Fc receptor with Fc, Nature, vol.372, pp.379-383, 1994. ,
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117, Nature, vol.522, pp.487-491, 2015. ,
Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation, MAbs, vol.7, pp.863-870, 2015. ,
An oligosaccharyltransferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana, Plant Biotechnol. J, vol.16, pp.1700-1709, 2018. ,
, The Authors, Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists, pp.1-13, 2019.
, Antibody engineering for Fc receptor binding 11
Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants, Infect. Immun, vol.73, pp.5915-5922, 2005. ,
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir, Proc. Natl Acad. Sci. USA, vol.111, pp.13151-13156, 2014. ,
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines, Sci. Transl. Med, vol.6, pp.228-238, 2014. ,
Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor, Nat. Biotechnol, vol.24, pp.1591-1597, 2006. ,
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial, Lancet HIV, vol.6, pp.297-306, 2019. ,
Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences, J. Immunol, vol.169, pp.5171-5180, 2002. ,
Modulation of antibody effector function, Exp. Cell Res, vol.317, pp.1278-1285, 2011. ,
The therapeutic monoclonal antibody market, MAbs, vol.7, pp.9-14, 2015. ,
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose, Proc. Natl Acad. Sci. USA, vol.108, pp.12669-12674, 2011. ,
Fc-glycosylation influences Fcgamma receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12, J. Immunol, vol.185, pp.6876-6882, 2010. ,
Towards an optimized in-vitro SPR assay for antibody Fc gamma receptor binding kinetics, GE Healthcare Life Sciences, 2015. ,
Effect of individual Fc methionine oxidation on FcRn binding: Met252 oxidation impairs FcRn binding more profoundly than Met428 oxidation, J. Pharm. Sci, vol.104, pp.368-377, 2015. ,
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges, Nature, vol.533, pp.105-109, 2016. ,
Relationship between protein structure and methionine oxidation in recombinant human alpha 1-antitrypsin, Biochemistry, vol.41, pp.6245-6252, 2002. ,
The function of Fcgamma receptors in dendritic cells and macrophages, Nat. Rev. Immunol, vol.14, pp.94-108, 2014. ,
Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions, J. Proteome Res, vol.13, pp.5471-5485, 2014. ,
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond, Nat. Rev. Drug Discov, vol.11, pp.311-331, 2011. ,
Protein-polyphenol reactions. 1. Nutritional and metabolic consequences of the reaction between oxidized caffeic acid and the lysine residues of casein, Brit. J. Nutr, vol.47, pp.191-211, 1982. ,
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases, 2015. ,
, Mol. Immunol, vol.67, pp.171-182
Glycosylation as a strategy to improve antibody-based therapeutics, Nat. Rev. Drug Discovery, vol.8, pp.226-234, 2009. ,
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action, Trends Pharmacol. Sci, vol.30, pp.356-362, 2009. ,
Isotype and glycoform selection for antibody therapeutics, Arch. Biochem. Biophys, vol.526, pp.159-166, 2012. ,
Significant impact of single N-glycan residues on the biological activity of Fc-based antibody-like fragments, J. Biol. Chem, vol.287, pp.24313-24319, 2012. ,
The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor, Proc. Natl Acad. Sci. USA, vol.93, pp.5512-5516, 1996. ,
Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer, Cancer Res, vol.70, pp.4481-4489, 2010. ,
An Agrobacterium-mediated transient gene expression system for intact leaves, Plant Sci, vol.122, pp.101-108, 1997. ,
Production of a diagnostic monoclonal antibody in perennial alfalfa plants, Biotechnol. Bioeng, vol.64, pp.135-143, 1999. ,
Function and glycosylation of plant-derived antiviral monoclonal antibody, Proc. Natl Acad. Sci. USA, vol.100, pp.8013-8018, 2003. ,
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection, Nature, vol.514, pp.642-645, 2014. ,
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults, Clin. Exp. Immunol, vol.182, pp.289-301, 2015. ,
Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody, PLoS ONE, vol.8, p.68772, 2013. ,
Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization, Biotechnol. Bioeng, vol.48, pp.490-500, 1995. ,
Study on the determination of polyphenols in tobacco by HPLC coupled with ESI-MS after solid-phase extraction, J. Chromatogr. Sci, vol.41, pp.36-40, 2003. ,
IgG-Fc glycoengineering in non-mammalian expression hosts, Arch. Biochem. Biophys, vol.526, pp.167-173, 2012. ,
Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies, Plant Biotechnol. J, vol.11, pp.1029-1033, 2013. ,
Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants, Plant Biotechnol. J, vol.13, pp.1106-1120, 2015. ,
Rhizosecretion improves the production of Cyanovirin-N in Nicotiana tabacum through simplified downstream processing, Biotechnol. J, vol.11, pp.910-919, 2016. ,
Stability of protein pharmaceuticals: an update, Pharm. Res, vol.27, pp.544-575, 2010. ,
Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding, Mol. Cell, vol.7, pp.867-877, 2001. ,
Combination therapy with anti-HIV-1 antibodies maintains viral suppression, Nature, vol.561, pp.479-484, 2018. ,
A plant-produced bacteriophage tailspike protein for the control of salmonella. Front. Plant Sci. 6, 1221. ª 2019 The Authors, Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists, pp.1-13, 2015. ,
Advanced plant-based glycan engineering, Front. Bioeng. Biotechnol, vol.6, p.81, 2018. ,
Interactions of immunoglobulins outside the antigen-combining site, Adv. Immunol, vol.82, pp.155-215, 2004. ,
Fcgamma receptors as regulators of immune responses, Nat. Rev. Immunol, vol.8, pp.34-47, 2008. ,
Structural insights into neonatal Fc receptor-based recycling mechanisms, J. Biol. Chem, vol.289, pp.7812-7824, 2014. ,
Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes, J. Immunol. Methods, vol.173, pp.207-217, 1994. ,
Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn, Protein Sci, vol.18, pp.424-433, 2009. ,
Target product selection -where can Molecular Pharming make the difference?, Curr. Pharm. Des, vol.19, pp.5478-5485, 2013. ,
Leaf protein -beneficiary of tribulation, Nature, vol.253, pp.239-241, 1975. ,
Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds, Nat. Biotechnol, vol.33, pp.1135-1137, 2015. ,
In vivo veritas: the surprising roles of Fc receptors in immunity, Nat. Immunol, vol.11, pp.183-185, 2010. ,
Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions, J. Exp. Med, vol.170, pp.481-497, 1989. ,
Randomized clinical trial to assess the impact of the broadly neutralizing HIV-1 monoclonal antibody VRC01 on HIV-1 persistence in individuals on effective ART, Open Forum Infect. Dis, vol.5, p.242, 2018. ,
Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems, PLoS ONE, vol.8, p.58724, 2013. ,
Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques, PLoS ONE, vol.10, p.120451, 2015. ,
pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants, Plant Biotechnol. J, vol.7, pp.682-693, 2009. ,
Characterization of plants expressing the human beta1,4-galactosyltrasferase gene, Plant Physiol. Biochem, vol.92, pp.39-47, 2015. ,
In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system, Biotechnol. J, vol.2, pp.700-708, 2007. ,
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity, J. Biol. Chem, vol.277, pp.26733-26740, 2002. ,
Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides, Proteomics, vol.8, pp.2858-2871, 2008. ,
Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure, Plant Biotechnol. J, vol.6, pp.392-402, 2008. ,
Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile, J. Biol. Chem, vol.284, pp.20479-20485, 2009. ,
Interactions of polyphenols with proteins in plants and plant products, Qual. Plant, vol.24, pp.337-350, 1975. ,
Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco, Plant Biotechnol. J, vol.12, pp.300-311, 2014. ,
Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor, Traffic, vol.7, pp.1127-1142, 2006. ,
, vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity, vol.10, p.134949, 2015.
Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice, Plant Biotechnol. J, vol.9, pp.1120-1130, 2011. ,
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int. J. Cancer, vol.26, pp.171-176, 1980. ,
Biochemical characterization of human anti-hepatitis B monoclonal antibody produced in the microalgae phaeodactylum tricornutum, PLoS ONE, vol.10, p.139282, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01841078
Structural basis of pH-dependent antibody binding by the neonatal Fc receptor, Structure, vol.6, pp.63-73, 1998. ,
Targeting FcRn for the modulation of antibody dynamics, Mol. Immunol, vol.67, pp.131-141, 2015. ,
Molecular basis for a polymorphism of human Fc gamma receptor II (CD32), 1990. ,
, J. Exp. Med, vol.172, pp.19-25
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1, Science, vol.329, pp.856-861, 2010. ,
Enhanced antibody half-life improves in vivo activity, Nat. Biotechnol, vol.28, pp.157-159, 2010. ,
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant, Proc. Natl Acad. Sci. USA, vol.108, pp.20690-20694, 2011. ,